肝脏Reptin/RUVBL2通过相反作用于mTORC1和mTORC2信号调控糖脂代谢
研究通过构建可诱导的肝脏特异性Reptin敲除小鼠模型,发现Reptin缺失导致小鼠体重和脂肪量下降、低血糖和低脂血症,伴随肝脏mTOR蛋白丰度降低。机制上,Reptin缺失或抑制对mTORC1和mTORC2信号产生相反效应:强烈抑制mTORC1活性,增强mTORC2活性。在高脂饮食诱导的胰岛素抵抗和非酒精性脂肪肝病模型中,Reptin缺失完全逆转了葡萄糖不耐受、高血糖、高脂血症和肝脏脂肪变性等病理表型。结论提示Reptin是肝脏mTOR信号和糖脂稳态的调节因子,抑制肝脏Reptin表达或活性可能为代谢综合征提供新的治疗视角。
要点
- 肝脏特异性Reptin敲除小鼠表现为体重和脂肪量下降、低血糖和低脂血症。
- Reptin缺失或抑制对mTORC1和mTORC2信号产生相反效应:抑制mTORC1,增强mTORC2。
- Reptin缺失完全逆转高脂饮食诱导的胰岛素抵抗相关病理表型。
核心结论
- AAA+ATP酶Reptin是肝脏mTOR信号和整体糖脂稳态的调节因子,抑制肝脏Reptin表达或活性为代谢综合征提供了新的治疗视角。
研究设计与样本
- 研究生成可诱导的肝脏特异性Reptin敲除(RepinLKO)小鼠模型,并在原代肝细胞中进行进一步实验。
主要发现
- Reptin失活后,小鼠体重和脂肪量下降,出现低血糖和低脂血症,伴随肝脏mTOR蛋白丰度降低。
- 原代肝细胞实验表明Reptin通过其ATP酶活性维持mTOR蛋白水平。
- Reptin缺失或抑制对mTORC1和mTORC2信号产生相反效应:强烈抑制肝脏mTORC1活性,可能负责减少肝细胞大小、降低de novo脂肪生成和胆固醇转录程序;增强mTORC2活性,伴随抑制糖异生转录程序和肝脏葡萄糖产生。
- 在高脂饮食诱导的胰岛素抵抗和非酒精性脂肪肝病模型中,Reptin缺失完全逆转了葡萄糖不耐受、高血糖、高脂血症和肝脏脂肪变性等病理表型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The AAA+ ATPase Reptin is overexpressed in hepatocellular carcinoma and preclinical studies indicate that it could be a relevant therapeutic target. However, its physiological and pathophysiological roles in vivo remain unknown. This study aimed to determine the role of Reptin in mammalian adult liver. DESIGN AND RESULTS: We generated an inducible liver-specific Reptin knockout (RepinLKO ) mouse model. Following Reptin invalidation, mice displayed decreased body and fat mass, hypoglycaemia and hypolipidaemia. This was associated with decreased hepatic mTOR protein abundance. Further experiments in primary hepatocytes demonstrated that Reptin maintains mTOR protein level through its ATPase activity. Unexpectedly, loss or inhibition of Reptin induced an opposite effect on mTORC1 and mTORC2 signalling, with: (1) strong inhibition of hepatic mTORC1 activity, likely responsible for the reduction of hepatocytes cell size, for decreased de novo lipogenesis and cholesterol transcriptional programmes and (2) enhancement of mTORC2 activity associated with inhibition of the gluconeogenesis transcriptional programme and hepatic glucose production. Consequently, the role of hepatic Reptin in the pathogenesis of insulin resistance (IR) and non-alcoholic fatty liver disease consecutive to a high-fat diet was investigated. We found that Reptin deletion completely rescued pathological phenotypes associated with IR, including glucose intolerance, hyperglycaemia, hyperlipidaemia and hepatic steatosis. CONCLUSION: We show here that the AAA +ATPase Reptin is a regulator of mTOR signalling in the liver and global glucido-lipidic homeostasis. Inhibition of hepatic Reptin expression or activity represents a new therapeutic perspective for metabolic syndrome.
引用
- Javary J, Allain-Courtois N, Saucisse N, et al. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut. 2017. PMID: 29074727. doi:10.1136/gutjnl-2017-314208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。